Akebia Therapeutics, Inc. Business Operations Contracts & Agreements
28 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Distribution Agreements (1)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Services Agreements (4)
- Supply Agreements (12)
- Termination Agreements (3)
- Voting Agreements (2)
- Termination and Settlement Agreement, dated July 10, 2024, by and between the Company and Vifor (International) Ltd (Filed With SEC on August 8, 2024)
- Amendment #2 to Supply Agreement, dated as of April 15, 2024, by and between the Company and STA Pharmaceutical Hong Kong Limited (Filed With SEC on August 8, 2024)
- Termination and Settlement Agreement, dated December 22, 2022, by and between Keryx Biopharmaceuticals, Inc. and BioVectra Inc (Filed With SEC on March 10, 2023)
- Amendment No. 1 to Collaboration Agreement, dated December 2, 2022, by and between Akebia Therapeutics, Inc. and Mitsubishi Tanabe Pharma Corporation (Filed With SEC on March 10, 2023)
- Termination and Settlement Agreement, dated (Filed With SEC on August 4, 2022)
- Amendment No. 4 to Master Manufacturing Services and Supply Agreement, dated as of December 17, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc (Filed With SEC on March 1, 2022)
- Master Manufacturing Services Agreement by and between Keryx Biopharmaceuticals, Inc. and Patheon Manufacturing Services LLC and certain of its affiliates, dated September 27,... (Filed With SEC on March 1, 2022)
- Collaboration Agreement between Akebia Therapeutics, Inc. and Mitsubishi Tanabe Pharma Corporation, dated December 11, 2015 (Filed With SEC on March 1, 2022)
- Amendment #1 to the Supply Agreement, dated as of April 15, 2021, by and between Akebia Therapeutics, Inc, and STA Pharmaceutical Hong Kong Limited (Filed With SEC on August 5, 2021)
- Supply Agreement, dated February 10, 2021, by and between the Company and STA Pharmaceutical Hong Kong Limited (Filed With SEC on May 10, 2021)
- Amendment No. 3 to Master Manufacturing Services and Supply Agreement, dated as of February 11, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc (Filed With SEC on February 25, 2021)
- Amendment No. 2 to Master Manufacturing Services and Supply Agreement, dated as of January 29, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc (Filed With SEC on February 25, 2021)
- Amendment No. 1 to Master Manufacturing Services and Supply Agreement, dated as of December 21, 2020, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc (Filed With SEC on February 25, 2021)
- Amended and Restated Product Manufacture and Supply and Facility Construction Agreement between BioVectra, Inc. and Keryx Biopharmaceuticals, Inc., dated September 4, 2020 (Filed With SEC on September 11, 2020)
- Supply Agreement, dated as of April 2, 2020, by and between Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited (Filed With SEC on August 10, 2020)
- Supply Agreement, dated as of March 11, 2020, by and between Akebia Therapeutics, Inc. and Patheon, Inc (Filed With SEC on May 5, 2020)
- Controlled Equity OfferingSM Amended and Restated Sales Agreement, dated as of November 12, 2019, by and between the Company and Cantor Fitzgerald & Co (Filed With SEC on November 12, 2019)
- Supply Agreement, dated as of April 9, 2019, by and between Akebia Therapeutics, Inc. and Esteve Qumica, S.A (Filed With SEC on August 8, 2019)
- Manufacture and Supply Agreement between Keryx Biopharmaceuticals, Inc. and BioVectra Inc., dated May 26, 2017 and Amendment to Manufacture and Supply Agreement between Keryx... (Filed With SEC on March 26, 2019)
- Exclusive Distribution Agreement between Keryx Biopharmaceuticals, Inc. and Cardinal Health 105, Inc., dated October 16, 2014 and Amendment to Exclusive Distribution Agreement... (Filed With SEC on March 26, 2019)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on March 12, 2018)
- CONFIDENTIAL COLLABORATION AGREEMENT BY AND BETWEEN AKEBIA THERAPEUTICS, INC. AND MITSUBISHI TANABE PHARMA CORPORATION (Filed With SEC on March 14, 2016)
- MASTER SERVICES AGREEMENT (Filed With SEC on August 11, 2015)
- AKEBIA THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on March 4, 2014)
- ADMINISTRATIVE SERVICES AGREEMENT (Filed With SEC on February 14, 2014)
- AMENDED AND RESTATED ADMINISTRATIVE SERVICES AGREEMENT (Filed With SEC on February 14, 2014)
- AMENDMENT NO. 1 TO THETHIRD AMENDED AND RESTATED VOTING AGREEMENT (Filed With SEC on February 14, 2014)
- THIRDAMENDED AND RESTATED VOTING AGREEMENT TABLE OF CONTENTS (Filed With SEC on February 14, 2014)
